CN111939234A - Gout electuary - Google Patents
Gout electuary Download PDFInfo
- Publication number
- CN111939234A CN111939234A CN202010932640.1A CN202010932640A CN111939234A CN 111939234 A CN111939234 A CN 111939234A CN 202010932640 A CN202010932640 A CN 202010932640A CN 111939234 A CN111939234 A CN 111939234A
- Authority
- CN
- China
- Prior art keywords
- gout
- powder
- rhizome
- traditional chinese
- ground
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 24
- 239000008187 granular material Substances 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 10
- 244000183914 Dianthus superbus Species 0.000 claims abstract description 8
- 235000013535 Dianthus superbus Nutrition 0.000 claims abstract description 8
- 241000239226 Scorpiones Species 0.000 claims abstract description 8
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 7
- 241000255789 Bombyx mori Species 0.000 claims abstract description 7
- 241000258920 Chilopoda Species 0.000 claims abstract description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 7
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 7
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 7
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract description 7
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract description 7
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 7
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 7
- 240000008042 Zea mays Species 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 claims abstract description 6
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 6
- 240000005717 Dioscorea alata Species 0.000 claims abstract description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 6
- 235000005822 corn Nutrition 0.000 claims abstract description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 6
- 235000011477 liquorice Nutrition 0.000 claims abstract description 6
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 4
- 235000005412 red sage Nutrition 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 15
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 6
- 230000001174 ascending effect Effects 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 8
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 229940116269 uric acid Drugs 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 208000005392 Spasm Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 238000009924 canning Methods 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 210000001255 hallux Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 244000132619 red sage Species 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241001063882 Smilax moranensis Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 210000003857 wrist joint Anatomy 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides gout granules, and relates to the field of traditional Chinese medicines. The gout electuary comprises the following components in percentage by weight: 50-70 g of glabrous greenbrier rhizome, 5-20 g of Chinese angelica, 5-20 g of yam rhizome, 5-20 g of tetrandra root, 5-20 g of peach seed, 5-20 g of fried stiff silkworm, 20-40 g of corn stigma, 5-20 g of scorpion, 5-20 g of centipede, 10-20 g of red sage root, 5-20 g of fringed pink, 5-20 g of oriental waterplantain rhizome, 5-20 g of rhizoma atractylodis, 10-20 g of amur corktree bark, 1-3 g of stevia rebaudiana and 3-10 g of liquorice. The traditional Chinese medicine is ground into powder, and a certain amount of boiled water is added to the powder for taking, so that the traditional Chinese medicine has the advantages of ascending the clear and descending the turbid, eliminating dampness and relieving pain, and has a short treatment period and obvious drug effect.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to gout granules.
Background
Gout is a chronic metabolic disease, and is a disease closely related to dietary structure caused by purine metabolic disorder and/or reduction of uric acid excretion. The medicament is mainly characterized in that the uric acid in a body is excessively produced or the excretion of uric acid by kidneys is reduced, so that the blood uric acid is increased and deposited on limbs, red swelling and hot pain are caused, dysfunction is caused, the course of disease is long, repeated attacks are easy to occur, and if the treatment is not carried out in time, arthrocele, deformity, stiffness, nodules, concurrent gouty stones, gouty renal failure, hyperlipidemia, hypertension and the like can be caused to damage the organism of a patient, so that the life of the patient is seriously threatened.
The ventilation granules on the market generally have poor treatment effect when in use, have long treatment period and increase treatment cost, so that gout granules with remarkable treatment and short treatment period are needed at present.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides gout granules, which solve the problems of poor treatment effect and long treatment period.
(II) technical scheme
In order to achieve the purpose, the invention is realized by the following technical scheme: the gout electuary comprises the following components in percentage by weight: 50-70 g of glabrous greenbrier rhizome, 5-20 g of Chinese angelica, 5-20 g of yam rhizome, 5-20 g of tetrandra root, 5-20 g of peach seed, 5-20 g of fried stiff silkworm, 20-40 g of corn stigma, 5-20 g of scorpion, 5-20 g of centipede, 10-20 g of red sage root, 5-20 g of fringed pink, 5-20 g of oriental waterplantain rhizome, 5-20 g of rhizoma atractylodis, 10-20 g of amur corktree bark, 1-3 g of stevia rebaudiana and 3-10 g of liquorice.
Preferably, the above traditional Chinese medicines are ground into powder.
Preferably, the ground powder can be bagged according to 6-8 g per bag or directly sealed and canned according to 200 g per can.
Preferably, 50-70ml of boiled water is added into each bag of 6-8 g of the traditional Chinese medicine powder.
The invention adopts the following medical analysis:
glabrous greenbrier rhizome: is the dry tuber of Smilax scobinicaulis C.H. Wright of Liliaceae, has effects of removing toxic substance, eliminating dampness, and smoothing joint movement, and can be used for treating skin ulcer, limb spasm, stranguria with turbid discharge, leukorrhagia, eczema, pruritus, carbuncle, swelling, and sore.
Whole Chinese angelica: plant of Umbelliferae family. It is mostly produced in alpine and rainy mountainous areas, mainly in Gansu, Yunnan, Sichuan, etc. Collected or dug in late autumn, the fibrous roots and the silt are removed, the mixture is bundled into small bundles after the water is slightly evaporated, and the small bundles are put on a shed and are slowly smoked to dry by fireworks. The main chemical components of the volatile oil are volatile oil, wherein ligustilide is the main component in the volatile oil. Dang Gui is a blood-qi-regulating herb, because it can regulate blood and dispel cold. For cough due to cold and heat, up-qi warming malaria, dysentery, headache, lumbago, pain of heart, abdomen and limbs, it is the essential herb for numbness syndrome.
Rhizoma Dioscoreae Septemlobae: induce diuresis to remove turbid pathogen, dispel wind to remove arthralgia. Stranguria with turbid discharge, pain in lumbar and knee joints, damp-heat sores and toxins.
Tetrandra root: it is indicated for facial distortion due to damp wind, hand and foot pain, phlegm retention, cough and dyspnea due to lung qi.
Peach kernel: promoting blood circulation to remove blood stasis or activating blood circulation to remove blood stasis, it is mainly used clinically to treat some diseases caused by blood stasis in the body.
B, stiff silkworm moxibustion: enter liver meridian, calm liver wind and stop wind, and also calm and alleviate pain.
Corn silk: has the effects of inducing diuresis to alleviate edema, promoting diuresis and removing jaundice.
Scorpion: has effects in calming endogenous wind, relieving spasm, removing toxic materials, resolving hard mass, dredging meridians, and relieving pain; it can be used for treating spasm, convulsion, pyocutaneous disease, toxic swelling, scrofula, tuberculosis, intractable arthralgia due to wind-damp, and intractable headache.
Centipede: has effects in calming endogenous wind, relieving spasm, removing toxic materials, resolving hard mass, dredging meridians, and relieving pain; it can be used for treating spasm, convulsion, pyocutaneous disease, toxic swelling, lymphoid tuberculosis, intractable arthralgia due to wind-damp, and intractable headache.
Red sage root: has effects of promoting blood circulation, regulating menstruation, removing blood stasis, relieving pain, cooling blood, resolving carbuncle, relieving restlessness, and tranquilizing. Can be used for treating menoxenia, amenorrhea, dysmenorrhea, puerperal abdominal pain due to blood stasis, cardialgia, abdominal pain, abdominal mass, traumatic injury, rheumatism, skin sore, carbuncle, toxic swelling, fever, dysphoria, unconsciousness, palpitation, and insomnia.
And (3) fringed pink: clearing heat, promoting diuresis, removing blood stasis, and dredging channels can be used for treating dysuria, gonorrhea, edema, amenorrhea, carbuncle, swelling, conjunctival congestion, nebula, and sore.
Rhizoma alismatis: can be used for treating dysuria, edema, abdominal distention, diarrhea, oliguria, phlegm retention, vertigo, pyretic stranguria, pain, and hyperlipidemia.
Rhizoma atractylodis: has effects of eliminating dampness, invigorating spleen, dispelling pathogenic wind, and dispelling cold; it can be used for treating syndrome of dampness obstruction in middle energizer, rheumatism, exterior syndrome due to wind-cold-dampness, nyctalopia, and dim and astringent eyes.
Phellodendron bark: has effects in clearing away heat, eliminating dampness, purging pathogenic fire, removing toxic materials, and removing bone steaming; can be used for treating leukorrhagia due to damp-heat, stranguria with astringency, dysentery due to damp-heat, jaundice, tinea pedis due to damp-heat, fistula, hectic fever due to yin deficiency, night sweat, spermatorrhea, pyocutaneous disease, toxic swelling, eczema, and pruritus.
Stevia rebaudiana: promoting the production of body fluid to quench thirst, and can be used for treating diabetes; lowering blood pressure, and can be used for treating hypertension.
Licorice root: clearing heat, it can dispel phlegm and relieve cough.
(III) advantageous effects
The invention provides gout granules. The method has the following beneficial effects:
1. in the invention, the rhizoma smilacis glabrae is added, so that the gout electuary has the effects of detoxifying, dehumidifying and easing joint movement.
2. According to the invention, the scorpion enables the gout electuary to have the effects of calming endogenous wind and relieving spasm, counteracting toxic substances and dissipating stagnation, and dredging collaterals and relieving pain.
3. In the invention, the dianthus superbus granules have the functions of clearing heat and promoting diuresis, removing blood stasis and freeing channels to treat dysuria, gonorrhea, edema, amenorrhea, carbuncle swelling, conjunctival congestion and nebula, and acute pyogenic infections.
4. The traditional Chinese medicine composition has the advantages of ascending the clear and descending the turbid, eliminating dampness and relieving pain, and has a short treatment period and obvious drug effect.
Detailed Description
The following will clearly and completely describe the technical solutions in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
the embodiment of the invention provides gout granules, which comprise the following components in parts by weight: 50 g of glabrous greenbrier rhizome, 5 g of Chinese angelica, 5 g of yam rhizome, 5 g of tetrandra root, 5 g of peach seed, 5 g of moxibustion stiff silkworm, 20 g of corn stigma, 5 g of scorpion, 5 g of centipede, 10 g of salvia miltiorrhiza, 5 g of fringed pink, 5 g of oriental waterplantain rhizome, 5 g of rhizoma atractylodis, 10 g of amur corktree bark, 1 g of stevia rebaudiana and 3 g of liquorice.
Grinding the above traditional Chinese medicines into powder, and bagging according to 6 g of the powder, or directly canning the ground powder in a sealed manner according to 200 g of the powder in a can, adding 50ml of boiled water into 6 g of the powder in each bag, and then cooling to a certain temperature for taking.
Example two:
the embodiment of the invention provides gout granules, which comprise the following components in parts by weight: 60 g of glabrous greenbrier rhizome, 10 g of Chinese angelica, 10 g of yam rhizome, 10 g of tetrandra root, 10 g of peach seed, 10 g of moxibustion stiff silkworm, 30 g of corn stigma, 10 g of scorpion, 10 g of centipede, 15 g of salvia miltiorrhiza, 10 g of fringed pink, 10 g of oriental waterplantain rhizome, 10 g of rhizoma atractylodis, 15 g of amur corktree bark, 2 g of stevia rebaudiana and 5 g of liquorice.
Grinding the above traditional Chinese medicines into powder, and bagging according to 7 g of the powder per bag, or directly canning the ground powder in a sealed manner according to 200 g of the powder per bag, adding 60ml of boiled water into 7 g of the powder per bag, and cooling to a certain temperature for taking.
Example three:
the embodiment of the invention provides gout granules, which comprise the following components in parts by weight: 70 g of glabrous greenbrier rhizome, 20 g of Chinese angelica, 20 g of yam rhizome, 20 g of tetrandra root, 20 g of peach seed, 20 g of moxibustion stiff silkworm, 40 g of corn stigma, 20 g of scorpion, 20 g of centipede, 20 g of salvia miltiorrhiza, 20 g of fringed pink, 20 g of oriental waterplantain rhizome, 20 g of rhizoma atractylodis, 20 g of amur corktree bark, 3 g of stevia rebaudiana and 10 g of liquorice.
Grinding the above traditional Chinese medicines into powder, and bagging according to 8 g of the powder, or directly canning the ground powder in a sealed manner according to 200 g of the powder in a can, adding 70ml of boiled water into 8 g of the powder in each bag, and then cooling to a certain temperature for taking.
Typical cases are:
the patient A is male, 45 years old. In 1990, the hallux joint had severe heat and pain, was light and heavy, could not land on the ground, and had pain in the wrist and elbow joints. The treatment by western medicines is not improved. In 1999, the joint pain of 7 months is large, groaning can not land, the blood uric acid concentration is increased by examination in a hospital in county, and the gout is diagnosed. After the medicine is taken from 8 months in 1999, the joints do not feel painful and the user can walk after taking the medicine for one week. After taking the medicine for four weeks, the joint movement and the appearance thereof are recovered to be normal, and the blood uric acid concentration is normal. And (5) curing.
Patient b, male, 42 years old. In 1997, severe heat pain in the hallux joint, inability to land on the ground, cold and heat, headache, palpitation and repeated attacks began to appear. The hallux joint was hot and painful in 9 months in 1999, had a large attack and could not land on the ground. Aversion to cold, headache, squash, increased blood uric acid concentration, and gout diagnosis. The gout granule treatment can ensure that the joint does not have pain and can walk after being taken for one week. After taking the medicine for four weeks, the joint movement and the appearance thereof are recovered to be normal, and the blood uric acid concentration is normal. And (5) curing.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (4)
1. The gout electuary is characterized by comprising the following components in percentage by weight: 50-70 g of glabrous greenbrier rhizome, 5-20 g of Chinese angelica, 5-20 g of yam rhizome, 5-20 g of tetrandra root, 5-20 g of peach seed, 5-20 g of fried stiff silkworm, 20-40 g of corn stigma, 5-20 g of scorpion, 5-20 g of centipede, 10-20 g of red sage root, 5-20 g of fringed pink, 5-20 g of oriental waterplantain rhizome, 5-20 g of rhizoma atractylodis, 10-20 g of amur corktree bark, 1-3 g of stevia rebaudiana and 3-10 g of liquorice.
2. The gout granules of claim 1, wherein: the above Chinese medicinal materials are ground into powder.
3. The gout granules of claim 1, wherein: the ground powder can be bagged according to 6-8 g per bag or directly canned by sealing the ground powder into cans according to 200 g per bag.
4. The gout granules of claim 1, wherein: 50-70ml of boiled water is added into each bag of 6-8 g of the traditional Chinese medicine powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010932640.1A CN111939234A (en) | 2020-09-08 | 2020-09-08 | Gout electuary |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010932640.1A CN111939234A (en) | 2020-09-08 | 2020-09-08 | Gout electuary |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111939234A true CN111939234A (en) | 2020-11-17 |
Family
ID=73356768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010932640.1A Pending CN111939234A (en) | 2020-09-08 | 2020-09-08 | Gout electuary |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111939234A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083592A (en) * | 2012-12-11 | 2013-05-08 | 宋协勘 | Traditional Chinese medicine for treating gouty arthritis |
| CN103705809A (en) * | 2013-12-23 | 2014-04-09 | 邵正荣 | Traditional Chinese medicine for curing gout |
-
2020
- 2020-09-08 CN CN202010932640.1A patent/CN111939234A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083592A (en) * | 2012-12-11 | 2013-05-08 | 宋协勘 | Traditional Chinese medicine for treating gouty arthritis |
| CN103705809A (en) * | 2013-12-23 | 2014-04-09 | 邵正荣 | Traditional Chinese medicine for curing gout |
Non-Patent Citations (1)
| Title |
|---|
| 单书健: "《重订古今名医临证金鉴. 痹症卷》", 31 August 2017, 中国医药科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579774B (en) | Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes | |
| CN105106797A (en) | Traditional Chinese medicine nursing composition for treating tenosynovitis | |
| CN104758743A (en) | Traditional Chinese medicine foot fumigating powder for treating rheumatism as well as preparation method and using method thereof | |
| CN111939234A (en) | Gout electuary | |
| CN107823363A (en) | Treat the traditional Chinese medicine for outer use and its production method of orthopaedic disease | |
| CN106511905A (en) | Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof | |
| CN1257745C (en) | Chinese medicinal composition for treating typhoid | |
| CN104958520A (en) | Traditional Chinese medicine for treating osteoarthritis | |
| CN104740450A (en) | Traditional Chinese medicine foot bath powder for treating rheumatism and preparation and application method of traditional Chinese medicine foot bath powder | |
| CN104800302A (en) | Externally applied plaster for treating thromboangiitis obliterans and preparation method | |
| CN103816238A (en) | Traditional Chinese medicine for treating goiter | |
| CN107469021A (en) | It is a kind of to be used to treat pill medicine of chest impediment and cardialgia and preparation method thereof | |
| CN107596189A (en) | One kind treats gout and arthritic capsule medicine and preparation method thereof | |
| CN101129651A (en) | Traditional Chinese medicine formulated product for treating cervical vertebra disease | |
| CN106924700A (en) | A kind of cervical vertebra thermotherapy Chinese medicine package and preparation method | |
| CN106421514A (en) | Traditional Chinese medicine for treating arthralgia | |
| CN101129505A (en) | Traditional Chinese medicine formulated product for treating cervical vertebra disease | |
| CN108853437A (en) | Outer emplastrum of precious jade medicine resisting hyperosteogeny and preparation method thereof | |
| CN105031073A (en) | Ointment for promoting blood circulation to remove blood stasis and preparation method of ointment | |
| CN114042128A (en) | Gout electuary | |
| CN108853453A (en) | A kind of Chinese medicine preparation that treating traumatic injury and preparation method | |
| CN104083649A (en) | Traditional Chinese medicine preparation for treating shoulder periarthritis | |
| CN101837115B (en) | Steamed and applied traditional Chinese medicine for promoting recovery after restoration of prolapse of lumbar intervertebral disc | |
| CN107714873A (en) | A kind of Chinese medicine composition and purposes | |
| CN112618671A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation, preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201117 |